I hope not. The Phase 3 is a pivotal event for Cynapsus, and we want 100% of the focus on ensuring that it runs smoothly. I don't think they are seriously thinking about other indications right now, but that it was merely a comment about where they could see it being used much farther down the road.
Legit question - do Tesla vehicles have a range? I guess I just assumed that they were limited to XXX amount of miles per charge or something like that.
Let's not get ahead of ourselves. But, if this does happen, I would gladly take a trip out to San Diego to meet some of the regulars on here over a steak dinner. I would be really curious to meet some of these characters in person! Haha. That would be a great night.
That's an entirely different type of scam, taget. That was fraudulent accounting which is not happening at ACAD. Unless they are fabricating the results of trials for the last 5-10 years (which seems impossible to me), I don't see how this is a scam at all.
Can you elaborate? Besides fear mongering. I am genuinely interested in hearing your thesis.
Not good - we need Anthony and CYNA to focus on treating OFF episodes first. Maximize the value there with a successful phase 3 and sell the company. This stock is too thinly traded. If they can prove with conviction that the strip works then we would see a massive revaluation from current levels.
More or less confirms that NUPLAZID is an effective treatment option over existing atypical antipsychotics for those with PDP.
Spader, I would imagine that today's appointments are helping to put you at ease. They seem like quality hires.
I agree. ACAD has definitely become one of the most hated biotechs post delay. It's hard to see a $5bn valuation with everything that's transpired - it's a little perplexing. But I think the tiny float is working its magic. The valuation is not ludicrous if they can get nuplazid into the hands of consumers. But I don't think the price is factoring in the inherent risk in having that happen.
Spader, I see what you're saying but again I get the same sense from this post as your other post. You seem to be looking for reasons to believe something is wrong with ACAD to validate that little voice in the back of your head screaming "it's a scam - get out now while you can" .. You make some good points though and I have not done any sort of analysis on the BBs buying patterns with their other stocks. My take on the matter was that they already had more than half a billion on the table and now the long side of their trade is right at $1 billion - in a single equity! With no revenue! Of course they are hedged on the short side - but even the most sophisticated investors with invest with prudence, no? If it's already a top 6 holding for them, they already own 20% of the company, they've got a guy on the BOD.. what more will they do? They are probably looking for companies that will grow 500% in the next 3-5 years, not double down on one that did it in the previous 3.
But you're right. Maybe they don't "love" ACAD but they certainly don't hate it.